Alexa, show me the future of drug advertising? Bayer Consumer Health’s first-ever Alexa interactive ad allows consumers to buy an OTC product by talking to the Amazon device—and may foreshadow broader trends in the industry. The U.K. ad for Bayer’s Berocca Boost, a vitamin and caffeine tablet, is running as a trial during programming streamed by Global,… Read More »
After years of having the previously untreated liver cancer market all to itself, Bayer’s Nexavar is getting its first major competition—and it’s coming from Roche’s Tecentriq. The FDA Friday cleared a combination of the checkpoint inhibitor and fellow Roche med Avastin for previously untreated patients with hepatocellular carcinoma, the most common form of the disease.… Read More »
Drugmakers are rushing to supply millions of doses of hydroxychloroquine, a cheap generic in testing as a possible treatment for COVID-19, after public interest sent demand through the roof. But donated batches of the antimalarial drug from Bayer—which haven’t been approved by the FDA—are drawing quality concerns. The U.S. government has grown worried that millions of doses of… Read More »
Bayer has come up zero for 3 in the first lawsuits alleging that Roundup herbicide caused cancer, with the latest verdict ordering the chemical giant to pay $ 2 billion to its victims. The verdict came from the third case, heard before the Alameda County Superior Court of California, in which a married couple, Alva… Read More »
For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »